UNSPSC 51451705: Ticarbodine

This classification denotes an antihelminthic agent with the molecular formula C15H19F3N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J4CLF34O60, chemically known as 1-piperidinecarbothioamide, 2,6-dimethyl-n-(3-(trifluoromethyl)phenyl)- but generally known as ticarbodine, which bears US NIH Compound Identifier 3034015. European Medicines Agency schedules Ticarbodine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11026MIG. The term TICARBODINE is an International Non-Proprietary Name.

UNSPSC 51451705 Ticarbodine, a Commodity code, nominally describes a single pharmaceutical agent, but recent state and local activity under this code shows actual procurement spanning naloxone (a life-safety medication used in opioid overdose response), safe drug deactivation systems, generic multi-source pharmaceuticals, over-the-counter products, and direct-to-manufacturer prescription fulfillment programs. The code captures a broad range of health-system and community-health-agency purchasing for pharmaceutical products, emergency medical supplies, and pharmacy benefit programs. Issuing bodies include county health departments (Seminole County, Florida), municipal fire departments and rescue divisions (City of Tampa), state health and human services agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local government facilities across multiple jurisdictions including Oregon).

Recent activity concentrates in Florida and Minnesota, with Texas representing exploratory procurement in pharmacy benefit innovation. Representative recent solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (IFB 60459723LAS, due July 26, 2023); the City of Tampa's sealed-bid invitation for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000.00, designated as a sheltered market opportunity for certified Small Local Business Enterprises (due March 13, 2026); the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local facilities, due March 26, 2026; and the Texas Health and Human Services Commission's RFI (HHS0017013) exploring direct-to-manufacturer prescription contracting models outside traditional pharmacy benefit manager and group purchasing organization channels (response deadline April 3, 2026). Municipal and county purchasing cycles vary, but RFP and IFB response windows typically run six to twelve weeks from posting.